Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Karen Canfell et al.   LANCET

Sustainable care for children with cancer: a Lancet Oncology Commission

(2020) Rifat Atun et al.   LANCET ONCOLOGY

Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis

(2020) Zachary J Ward et al.   LANCET ONCOLOGY

The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis

(2020) Zachary J Ward et al.   LANCET ONCOLOGY

Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study

(2019) Longfei Lin et al.   Journal of Hematology & Oncology

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

(2018) Claudia Allemani et al.   LANCET

Bringing down the cost of cancer treatment

(2018) Elie Dolgin   NATURE

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

(2017) Hongchao Pan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evidence-based indications for the use of PET-CT in the United Kingdom 2016

(2016) The Royal College of Radiologists et al.   CLINICAL RADIOLOGY

PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries’ Budgeted Funds, 2004–14

(2016) Corrina Moucheraud et al.   HEALTH AFFAIRS

Expanding global access to radiotherapy

(2015) Rifat Atun et al.   LANCET ONCOLOGY

Global health 2035: a world converging within a generation

(2013) Dean T Jamison et al.   LANCET

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

(2012) Freddie Bray et al.   LANCET ONCOLOGY

Expansion of cancer care and control in countries of low and middle income: a call to action

(2010) Paul Farmer et al.   LANCET

Cost Effectiveness in Low- and Middle-Income Countries

(2009) Samuel D. Shillcutt et al.   PHARMACOECONOMICS

Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry

(2008) Bruce E. Hillner et al.   JOURNAL OF CLINICAL ONCOLOGY

PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study

(2008) A. M. Scott et al.   JOURNAL OF NUCLEAR MEDICINE